| Mucosal Melanoma studied in …STUDIED_INderived74 of 74show fewer |
|---|
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 74 trials mapped (29 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07400302Phase 2 · recruiting Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076550Phase 1 · terminated A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506153Phase 3 · active not recruiting Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318717Phase 2 · recruiting Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma · condition mapped ALIAS · 74 trials mapped (29 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600476Phase 1 · recruiting A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698019Phase 2 · active not recruiting A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03178123Phase 2 · terminated The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098210Phase 1 · recruiting Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07230613Phase 2 · recruiting Neo-adjuvant Immunotherapy in Patients With Localized Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06424626Phase 1 · enrolling by invitation A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614828Phase 2 · withdrawn Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa · condition mapped ALIAS · 74 trials mapped (29 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215988recruiting Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01989572Phase 3 · completed Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662694not yet recruiting CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma · condition mapped ALIAS · 74 trials mapped (29 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319196Phase 2 · recruiting Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05341349Phase 1 · terminated Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628883Phase 1 · completed Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07506447completed The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858869Phase 1 · completed Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999980Phase 2 · recruiting Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384496Phase 2 · recruiting Axitinib and Nivolumab for the Treatment of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645680Phase 2 · active not recruiting Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03865212Phase 1 · terminated Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347444Phase 2 · not yet recruiting Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07336979Phase 2 · recruiting Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07236528Phase 2 · not yet recruiting Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155317Phase 2 · recruiting Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03611868Phase 1/Phase 2 · active not recruiting A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830124Phase 2 · terminated Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436990Phase 2 · terminated Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033576Phase 2 · completed Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05420324Phase 2 · completed A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05169957Phase 1 · completed Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03319693completed Molecular Characterization of Primary Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05545969Phase 2 · withdrawn Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519322Phase 2 · completed Neoadjuvant and Adjuvant Checkpoint Blockade · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978443Phase 2 · terminated A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879654Phase 2 · unknown Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery · condition mapped ALIAS · 74 trials mapped (29 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02126579Phase 1/Phase 2 · completed Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482074Phase 2 · withdrawn Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904120Phase 1 · completed Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041724Phase 2 · unknown Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748564Phase 2 · terminated Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241186Phase 2 · active not recruiting Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551352Phase 1 · completed A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04353050NA · unknown Atypical MOLes and Melanoma Early Detection Study (MoleMed) · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04180995Phase 2 · unknown Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462965Phase 2 · unknown Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129075Phase 2 · completed A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009446early Phase 1 · unknown Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622566Phase 2 · not yet recruiting Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04472806Phase 2 · unknown Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158520Phase 2 · completed Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941795Phase 2 · unknown Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma · condition mapped CURATED_BROADER · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602547Phase 2 · unknown Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03986515Phase 2 · unknown Apatinib Plus SHR1210 in Advanced Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788775Phase 2 · completed Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220009Phase 2 · withdrawn Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01961115Phase 2 · completed Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03138642Phase 2 · unknown Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01395121Phase 2 · completed A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424515Phase 2 · completed Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577382Phase 2 · completed SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110019Phase 3 · completed Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085189Phase 2 · completed Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01166126Phase 2 · terminated Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV · condition mapped ONTOLOGY_EXACT · 74 trials mapped (29 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |